Thermo Fisher Scientific Inc (NYSE:TMO) Analyst Rating Consensus

Thermo Fisher Scientific Inc (NYSE:TMO) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.41 by 16 Brokerage Firm. 13 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 1 Brokerage Firms have advised hold. 1 Analysts have rated it as strong sell.

Other Equity analysts have also commented on the company shares. Equity analysts at the Brokerage firm Jefferies downgrades its rating on Thermo Fisher Scientific Inc (NYSE:TMO). The rating major has initiated the coverage with hold rating on the shares. Earlier, the shares were rated a Buy by the brokerage firm. The rating by the firm was issued on April 29, 2016.

Thermo Fisher Scientific Inc (NYSE:TMO) stock has received a short term price target of $ 160.25 from 12 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $18.19. The higher estimate of target price is $173 , while the lower price target estimate is $105

Thermo Fisher Scientific Inc (NYSE:TMO) rose 0.36% or 0.54 points on Tuesday and made its way into the gainers of the day. After trading began at $148.95 the stock was seen hitting $150.09 as a peak level and $148.39 as the lowest level. The stock ended up at $148.91. The daily volume was measured at 1,257,884 shares. The 52-week high of the share price is $154.81 and the 52-week low is $117.1. The company has a market cap of $58,598 million.

Shares of Thermo Fisher Scientific, Inc. rose by 0.63% in the last five trading days and 0.14% for the last 4 weeks. Thermo Fisher Scientific, Inc. is up 7.35% in the last 3-month period. Year-to-Date the stock performance stands at 5.2%.

Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, provides instruments, consumables, software and services that are used in the laboratory; Specialty Diagnostics, offers diagnostic test kits, reagents, culture media, instruments and associated products, and Laboratory Products and Services, offers self-manufactured and sourced products for the laboratory.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.